Predictive Value of Optical Coherence Tomography Biomarkers in Patients with Persistent Diabetic Macular Edema Undergoing Cataract Surgery Combined with a Dexamethasone Intravitreal Implant
Bioengineering · 21.05.2025 · 12 (5) · 556
DOI: 10.3390/bioengineering12050556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering, online erschienen am 21.05.2025. Verfasst von Giuseppe Fasolino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Brussels, Laarbeeklaan 101, 1090 Jette, Belgium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Ophthalmlogy, University Hospital Brussels.
Abstract (Originalsprache)
Background
Diabetic macular edema (DME) is the most common cause of vision loss among diabetic patients. The first-line treatments for DME are anti-vascular endothelial growth factor (VEGF)-drugs, while intravitreal steroids are generally reserved for second-line treatment. Limited data exist on the role of optical coherence tomography (OCT) biomarkers as predictors of success in non-responders to anti-VEGF treatment undergoing simultaneous cataract surgery and dexamethasone intravitreal implant (DEX-I).
Methods
This study was designed as a retrospective analysis of patients with DME who were refractory to anti-VEGF treatment but underwent cataract surgery and received a DEX-I at the time of surgery. All procedures were performed between May 2021 and February 2024. The best-corrected visual acuity (BCVA) and central subfoveal thickness (CST) were recorded at baseline and at 1 week, 1 month, and 3 months. The following OCT-based biomarkers were also collected: ellipsoid zone (EZ) integrity, disorganization of the retinal inner layers (DRIL), CST, and hyperreflective foci (HRF). Correlations between the baseline biomarkers and the anatomical outcome were analyzed using linear mixed models (LMMs).
Results
Eleven patients (eighteen eyes) met the inclusion criteria. The mean CST decreased significantly from 469.4 ± 53.8 µm at baseline, to 373.1 ± 34.7 µm at 1 week (p = 0.002) and 354.4 ± 24.1 µm at 1 month (p = 0.011). The mean BCVA improved significantly from 0.47 LogMAR to 0.33 LogMAR at 1 week (p = 0.001), 0.23 LogMAR at 1 month (p < 0.001), and 0.25 LogMAR at 3 months (p < 0.001). Baseline predictors significantly influencing CST included the presence of DRIL, a disrupted/absent EZ, and a higher CST.
Conclusions
The administration of DEX-I for DME refractory to anti-VEGF treatment in patients undergoing cataract surgery promoted functional improvements persisting longer than the anatomical ones. Patients presenting with DRIL, disrupted EZ, and higher CST at baseline may be better candidates for the combination of DEX-I and cataract surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Brussels, Laarbeeklaan 101, 1090 Jette, Belgium.
- Department of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.
Förderung
- Department of Ophthalmlogy, University Hospital Brussels
Zitieren
APA
Fasolino, G., Lazaar, M., Della Rocca, D. G., Oellerich, S., & Ní Dhubhghaill, S. (2025). Predictive Value of Optical Coherence Tomography Biomarkers in Patients with Persistent Diabetic Macular Edema Undergoing Cataract Surgery Combined with a Dexamethasone Intravitreal Implant. Bioengineering, 12(5), 556. https://doi.org/10.3390/bioengineering12050556
Vancouver
Fasolino G, Lazaar M, Della Rocca DG, Oellerich S, Ní Dhubhghaill S. Predictive Value of Optical Coherence Tomography Biomarkers in Patients with Persistent Diabetic Macular Edema Undergoing Cataract Surgery Combined with a Dexamethasone Intravitreal Implant. Bioengineering. 2025;12(5):556. doi:10.3390/bioengineering12050556
BibTeX
@article{Fasolino2025,
author = {Fasolino, Giuseppe and Lazaar, Maryam and Della Rocca, Domenico Giovanni and Oellerich, Silke and Ní Dhubhghaill, Sorcha},
title = {Predictive Value of Optical Coherence Tomography Biomarkers in Patients with Persistent Diabetic Macular Edema Undergoing Cataract Surgery Combined with a Dexamethasone Intravitreal Implant},
journal = {Bioengineering},
year = {2025},
volume = {12},
number = {5},
pages = {556},
doi = {10.3390/bioengineering12050556}
}
EUVIMED